insights_auto
Why is NEO up ၃.၈၈%?
Dive Deeperchevron_right
NEO:NASDAQ
NeoGenomics, Inc.
၁၈.၄၇ US$
arrow_upward
+၃.၈၈%(+၀.၆၉) 1D
၁၈.၄၇ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: အောက် ၂, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEO...
Open
၁၇.၉၉ US$
High
၁၈.၆၉ US$
Low
၁၇.၉၄ US$
Mkt. cap
၂၃၇.၂၉ ဋေ
Avg. vol.
၂.၀၅ သန်း
Volume
၂.၃၀ သန်း
52-wk high
၂၀.၀၅ US$
52-wk low
၇.၀၆ US$
EPS
-၀.၄၀ US$
Beta
၁.၇၉
Shares outstanding
၁၂.၈၅ ကုဋေ
No. of employees
၂ ထောင်
Open
၁၇.၉၉ US$
High
၁၈.၆၉ US$
Low
၁၇.၉၄ US$
Mkt. cap
၂၃၇.၂၉ ဋေ
Avg. vol.
၂.၀၅ သန်း
Volume
၂.၃၀ သန်း
52-wk high
၂၀.၀၅ US$
52-wk low
၇.၀၆ US$
EPS
-၀.၄၀ US$
Beta
၁.၇၉
Shares outstanding
၁၂.၈၅ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ ရက်
NeoGenomics, Inc. (NEO) Stock Forecasts
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees၂.၅ ထောင်
Founded၂၀၀၂
Headquartersဖေါ့တ်မိုင်ရာစ်, ဖလော်ရီဒါပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth care provider
Websiteneogenomics.com